Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents

Adisorn Lumpaopong1, Chalermkiet Tuntrakool, Prapaipim Thirakhupt

  • 1Pediatric Nephrology Division, Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand.

Insights

High blood pressure is common in children with end-stage renal disease (ESRD) and is linked to left ventricular hypertrophy (LVH). Monitoring blood pressure and LVH is crucial for preventing heart problems in these young patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular disease is a leading cause of mortality in end-stage renal disease (ESRD) patients.
  • Left ventricular hypertrophy (LVH) is a known risk factor for cardiovascular events.
  • Limited research exists on LVH prevalence and its correlates in pediatric chronic dialysis patients.

Purpose of the Study:

  • To determine the prevalence of LVH in children undergoing chronic dialysis.
  • To identify clinical and laboratory parameters correlated with left ventricular mass index (LVMI) in this population.

Main Methods:

  • Retrospective review of 14 pediatric patients (11 hemodialysis, 3 peritoneal dialysis) at Phramongkutklao Hospital.
  • Echocardiography was used to diagnose LVH and calculate LVMI.
  • Clinical and laboratory data were analyzed to compare parameters between patients with and without LVH.

Main Results:

  • The prevalence of LVH was 57% among the studied pediatric dialysis patients.
  • Patients with LVH exhibited significantly higher systolic blood pressure (SBP) and diastolic blood pressure (DBP).
  • Blood pressure showed a positive correlation, while patient age showed a negative correlation with LVMI.

Conclusions:

  • Elevated blood pressure is significantly associated with left ventricular hypertrophy in pediatric chronic dialysis patients.
  • Regular echocardiographic monitoring and long-term follow-up are recommended to mitigate cardiovascular risks.
  • Early detection and management of hypertension are vital for preventing cardiovascular morbidity and mortality in this vulnerable group.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...